Sensus Healthcare, Inc. (SRTS) |
|
6.37 -0.09 (-1.39%)
|
12-07 16:00 |
|
Open: |
6.44 |
Pre. Close: |
6.46 |
|
High:
|
6.58 |
Low:
|
6.34 |
|
Volume:
|
166,909 |
Market Cap:
|
106(M) |
|
|
|
Technical analysis |
as of: 2022-12-07 4:26:22 PM |
|
Overall:
|
 |
| Stoxline posted a NEUTRAL today, same as yesterday. Current trend continues, but could change at anytime. It is not a good time to buy or sell. |
| Target: |
Six months: 13.15  One year: 16.9 |
| Support: |
Support1: 6.06 Support2: 5.04 |
| Resistance: |
Resistance1: 11.25 Resistance2: 14.47 |
| Pivot: |
6.56 |
| Moving Average: |
MA(5): 6.57 MA(20): 6.82
MA(100): 11.29 MA(250): 9.7 |
| MACD: |
MACD(12,26): -1.1  Signal(9): -1.3 |
| Stochastic oscillator: |
%K(14,3): 22.1 %D(3): 26.2 |
| RSI: |
RSI(14): 31.4 |
| 52-week: |
High: 15.25 Low: 5.84 |
| Average Vol(K): |
3-Month: 442 (K) 10-Days: 259 (K) |
|
Price, moving averages and Bollinger Bands |
|
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.[ SRTS ] has closed above bottom band by 28.0%. Bollinger Bands are 78.4% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 8 bars. This is a sign that the market may be about to initiate a new trend. |
|
|
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
6.59 - 6.64 |
6.64 - 6.68 |
|
Low:
|
6.23 - 6.29 |
6.29 - 6.33 |
|
Close:
|
6.29 - 6.38 |
6.38 - 6.44 |
|
Company Description |
|
Sensus Healthcare, Inc., a medical device company, manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy (SRT), a low-energy X-ray technology in its portfolio of treatment devices. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers, as well as other skin conditions, such as keloids; and SRT-100 Vision, which provides the user with a SRT-tailored treatment planning application that integrates the embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters. The company also provides SRT-100 Plus; Sentinel service program, which offers its customers protection for their systems; and in-office laser rental services. In addition, it sells disposable lead shielding replacements; and disposable radiation safety items, such as aprons and eye shields, ultrasound probe film, and disposable applicator tips to treat various sized lesions and various areas of the body. Sensus Healthcare, Inc. was incorporated in 2010 and is headquartered in Boca Raton, Florida. |
Headline News |
Tue, 06 Dec 2022
The dual role of SRT - True Citizen
Tue, 06 Dec 2022
AUCTION: Turbocharged 2004 Ram SRT-10 VCA Edition. - Mopar Insiders
Tue, 06 Dec 2022
SRT will compensate families of those killed by Tuesday's bomb in Songkhla - Thai PBS World
Mon, 05 Dec 2022
SRT's dining carriages back in service - Bangkok Post
Sun, 04 Dec 2022
THE MANUAL IS BACK: 6-Speed Returns To 2023 Dodge Challenger SRT HELLCAT! - Mopar Insiders
Thu, 01 Dec 2022
SRT Brings Back A Gold Country Christmas Favorite - Merced County Times
|
Financial Analysis |
| Price to Book Value: |
Outperform |
| P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
| Price to Earnings: |
Outperform |
| PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
| Discounted cash flow: |
Outperform |
| DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
| Return on Assets: |
Neutral |
| ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
| Return on Equity: |
Neutral |
| ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
| Debt to Equity: |
Neutral |
| evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: NASDAQ |
| Sector: Healthcare |
| Industry: Medical Devices |
| Shares Out. |
0 (M) |
| Shares Float |
17 (M) |
|
% Held by Insiders
|
1.307e+007 (%) |
|
% Held by Institutions
|
23.1 (%) |
|
Shares Short
|
548 (K) |
|
Shares Short P.Month
|
0 (K) |
Stock Financials |
|
EPS
|
1.55 |
|
EPS Est Next Qtl
|
-0.06 |
|
EPS Est This Year
|
-0.34 |
|
EPS Est Next Year
|
-0.16 |
|
Book Value (p.s.)
|
0.1 |
|
Profit Margin (%)
|
60.1 |
|
Operating Margin (%)
|
35.9 |
|
Return on Assets (ttm)
|
24.8 |
|
Return on Equity (ttm)
|
78.9 |
|
Qtrly Rev. Growth
|
63 |
|
Gross Profit (p.s.)
|
2.26533e+007 |
|
Sales Per Share
|
5.92667e+007 |
|
EBITDA (p.s.)
|
2.19333e+007 |
|
Qtrly Earnings Growth
|
1 |
|
Operating Cash Flow
|
0 (M) |
|
Levered Free Cash Flow
|
7 (M) |
Stock Valuations |
|
PE Ratio
|
4.08 |
|
PEG Ratio
|
0 |
|
Price to Book value
|
63.69 |
|
Price to Sales
|
0 |
|
Price to Cash Flow
|
1.68 |
Stock Dividends |
|
Dividend
|
0 |
|
Forward Dividend
|
862590 |
|
Dividend Yield
|
0% |
|
Dividend Pay Date
|
Invalid DateTime. |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
Your Ad Here
|
|
